1. Home
  2. SILO vs WNW Comparison

SILO vs WNW Comparison

Compare SILO & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • WNW
  • Stock Information
  • Founded
  • SILO 2010
  • WNW 2015
  • Country
  • SILO United States
  • WNW China
  • Employees
  • SILO N/A
  • WNW N/A
  • Industry
  • SILO Apparel
  • WNW Catalog/Specialty Distribution
  • Sector
  • SILO Consumer Discretionary
  • WNW Consumer Discretionary
  • Exchange
  • SILO Nasdaq
  • WNW Nasdaq
  • Market Cap
  • SILO 5.9M
  • WNW 5.4M
  • IPO Year
  • SILO N/A
  • WNW 2020
  • Fundamental
  • Price
  • SILO $0.70
  • WNW $1.87
  • Analyst Decision
  • SILO
  • WNW
  • Analyst Count
  • SILO 0
  • WNW 0
  • Target Price
  • SILO N/A
  • WNW N/A
  • AVG Volume (30 Days)
  • SILO 948.9K
  • WNW 108.6K
  • Earning Date
  • SILO 11-11-2025
  • WNW 11-14-2025
  • Dividend Yield
  • SILO N/A
  • WNW N/A
  • EPS Growth
  • SILO N/A
  • WNW N/A
  • EPS
  • SILO N/A
  • WNW 9.06
  • Revenue
  • SILO $72,102.00
  • WNW $158,485.00
  • Revenue This Year
  • SILO $1.86
  • WNW N/A
  • Revenue Next Year
  • SILO N/A
  • WNW N/A
  • P/E Ratio
  • SILO N/A
  • WNW $0.23
  • Revenue Growth
  • SILO N/A
  • WNW N/A
  • 52 Week Low
  • SILO $0.41
  • WNW $0.95
  • 52 Week High
  • SILO $3.37
  • WNW $70.00
  • Technical
  • Relative Strength Index (RSI)
  • SILO 53.25
  • WNW 46.72
  • Support Level
  • SILO $0.58
  • WNW $2.00
  • Resistance Level
  • SILO $0.83
  • WNW $2.29
  • Average True Range (ATR)
  • SILO 0.05
  • WNW 0.38
  • MACD
  • SILO 0.01
  • WNW -0.01
  • Stochastic Oscillator
  • SILO 45.56
  • WNW 10.36

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.

Share on Social Networks: